Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISDF for the Treatment of Psoriasis
NCT05295979Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2023
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
A Phase 2 trial of Inflammatory skin disease formula in psoriasis, sponsored by The Chinese University of Hong Kong. Started Mar 2023; status: completed.
02
Drugs
Inflammatory skin disease formula
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT05295979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05295979.